Skip to main content
Clinical Trials/NCT05894265
NCT05894265
Recruiting
N/A

Prospective Pilot Study to Determine the Safety and Effectiveness of a Connective Tissue Allograft (Active Matrix) vs. Standard of Care in Arthroscopic Rotator Cuff Repair

The University of Texas Health Science Center, Houston2 sites in 1 country72 target enrollmentJune 14, 2023

Overview

Phase
N/A
Intervention
ActiveMatrix® Dosage A
Conditions
Rotator Cuff Tears
Sponsor
The University of Texas Health Science Center, Houston
Enrollment
72
Locations
2
Primary Endpoint
Change in Sugaya score as measured by Magnetic Resonance Imaging (MRI)
Status
Recruiting
Last Updated
3 days ago

Overview

Brief Summary

The purpose of this study is to see how well the ActiveMatrix® graft works at improving healing and function of the shoulder following rotator cuff repair surgery

Registry
clinicaltrials.gov
Start Date
June 14, 2023
End Date
August 1, 2026
Last Updated
3 days ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Eric F Berkman

Assistant Professor

The University of Texas Health Science Center, Houston

Eligibility Criteria

Inclusion Criteria

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for the duration of the study
  • 1-2 tendon full thickness reparable rotator cuff tendon tear(s)
  • Reparable tear defined as:
  • a tear of the rotator cuff where it is possible to bring the retracted tendon edge back to the greater tuberosity of the humerus under minimal tension.
  • Full-thickness tear defined as:
  • a tear that involves the majority of supraspinatus and less than half of the infraspinatus under minimal tension, with no subscapularis involvement beyond the upper border
  • Failed conservative medical management of the rotator cuff tendon tear defined as: 4-6 weeks of formal physical therapy or guided home exercises and activity modification
  • Have no contraindications or allergies to the treatment administered
  • Have current imaging studies (plain radiographs and MRI exams) of the shoulder to rule out other etiologic diagnoses

Exclusion Criteria

  • Prior surgery on the index shoulder within 12 months of enrollment, including Latarjet procedures, superior labral treat from anterior to posterior (SLAP), and (failed) primary rotator cuff surgery,
  • Prior surgery for bone defects requiring bone implantation in the index shoulder,
  • Steroid injection into the index shoulder within 6 weeks of enrollment.
  • Subscapularis tear greater than 1/3 of tendon involvement requiring repair,
  • Calcific tendonitis in the index shoulder,
  • Fatty infiltration of the index shoulder rotator cuff muscle, i.e. Goutallier classification ≥ Grade 3,
  • Contralateral shoulder injury that may interfere with the post-operative rotator cuff repair rehab guidelines,
  • History of advanced osteoarthritis of glenohumeral joint (AC joint can have advanced OA) i.e. Samilson-Prieto classification ≥ Grade 2
  • History of malignant tumor and osseous metastatic disease,
  • History of heterotopic ossification,

Arms & Interventions

ActiveMatrix® Dosage A

Intervention: ActiveMatrix® Dosage A

ActiveMatrix® Dosage B

Intervention: ActiveMatrix® Dosage B

Saline Injection

Intervention: Saline injection

Outcomes

Primary Outcomes

Change in Sugaya score as measured by Magnetic Resonance Imaging (MRI)

Time Frame: 6 months post surgery , 12 months post surgery

Sugaya classification is a classification system that is used to analyze postoperative rotator cuff tendon integrity

Secondary Outcomes

  • Change in shoulder function as assessed by the American Shoulder and Elbow Surgeons Shoulder Score (ASES)(baseline, 4weeks, 3 months, 6 months 9 months, and 12 months)
  • Change in range of motion as assessed by the Passive Range of Motion (PROM) assessment using a goniometer(baseline, 4weeks, 3 months, 6 months 9 months, and 12 months)
  • Change in pain intensity as assessed by the Visual Analog Scale (VAS)(baseline, 4weeks, 3 months, 6 months 9 months, and 12 months)
  • Change in pain and functional disability as assessed by the Shoulder Pain and Disability Index (SPADI)(baseline, 4weeks, 3 months, 6 months 9 months, and 12 months)

Study Sites (2)

Loading locations...

Similar Trials